Quantum X Labs Inc. — Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2026. Financial amounts are in U.S. dollars and, unless stated otherwise, in thousands. The statements are unaudited. The company changed its name from Viewbix Inc. to Quantum X Labs Inc. and its Nasdaq ticker from VBIX to QXL effective April 30, 2026.
Business context
The company combines digital advertising and enterprise AI activities with a newly acquired quantum-technology business. Gix Media operates the search advertising platform; Metagramm develops AI writing tools; and Quantum Israel is developing quantum computing, sensing, navigation and security technologies. Quantum Israel currently generates no revenue. The former digital-content business, Cortex, was sold in November 2025 and is presented as discontinued operations in the 2025 comparison.
Key financial metrics
| Metric | Nine months ended September 30 | Three months ended September 30 |
|---|---|---|
| Revenue | 2026: $900; 2025: $1,300 | 2026: $254; 2025: $401 |
| Operating loss | 2026: $(3,993); 2025: $(1,603) | 2026: $(2,048); 2025: $(525) |
| Net loss | 2026: $(4,067); 2025: $(20,215) | 2026: $(5,879); 2025: $(3,953) |
| Net loss per share, basic and diluted | 2026: $(0.25); 2025: $(2.42) | 2026: $(0.28); 2025: $(0.32) |
| Operating cash flow from continuing operations | 2026: $(2,847); 2025: $(2,555) | 2026: $(1,251); 2025: $(2,266) |
| Investing cash flow from continuing operations | 2026: $(239); 2025: $12 | 2026: $(126); 2025: $0 |
| Financing cash flow from continuing operations | 2026: $4,563; 2025: $4,058 | 2026: $1,409; 2025: $1,925 |
The filing does not present gross profit or a clearly defined gross margin. Revenue declined approximately 31% year over year for the nine-month period and 37% for the quarter. The operating loss widened despite lower reported net losses year to date, primarily because 2025 included large fair-value financing expenses and discontinued-operation losses.
At September 30, 2026, cash and cash equivalents were $2,373, restricted deposits were $142, and current assets and current liabilities were $3,599 and $3,469, respectively, yielding reported positive working capital of $130. Total assets were $28,867; total liabilities were $6,476; and shareholders’ equity was $22,391. Loans totaled $1,102, including $1,024 of bank loans and current maturities and $78 of short-term convertible loans. The balance sheet reports no non-current loans at period end. Cash and restricted cash at period end totaled $2,515.
Material changes and unusual items
- Revenue from Gix Media’s search platform fell to $877 for the nine months from $1,280. Management attributed the decline in direct-model revenue to browser technology changes that reduced product distribution. Indirect-model revenue rose to $242 from zero, partly through third-party strategic partners.
- The March 2026 acquisition of Quantum Israel added substantial technology and goodwill, increased R&D and administrative expenses, and contributed $1,110 to operating loss for the nine-month period. The acquisition consideration included shares and pre-funded warrants, with potential additional earn-out securities of up to 12,702,847 shares or warrants upon milestone achievement.
- In June 2026, Quantum Israel lost control of CliniQuantum after a third party acquired 54.01% of its shares. The company retained an equity-method investment reported at $3,767 at September 30. The filing’s reported deconsolidation loss is inconsistent: the statements and segment table show $9 for the nine months but $3,840 for the third quarter, while management says the $3,840 was recognized in the third quarter following a measurement-period update. This requires verification.
- The company received $1,400 gross proceeds from a March 2026 private placement and $4,036 from warrant exercises during the nine months. It reported total warrant-exercise proceeds of $4,276 from June through October 2026. Outstanding shares were 21,867,826 at September 30 and 22,125,921 on November 18, 2026.
- Goodwill and intangible assets increased substantially, to $10,229 and $10,352, respectively, at September 30, mainly reflecting the Quantum Israel acquisition. The company also reported $3,767 in equity-method investments and $2,281 of deferred tax liabilities, mainly related to that acquisition.
Outlook, risks and contingencies
Management states that declining search and former digital-content revenues, recurring operating losses, Quantum Israel’s current lack of revenue, and related cash requirements raise substantial doubt about the company’s ability to continue as a going concern for the 12 months following issuance of the financial statements. Management describes cost reductions and efforts to develop partnerships and new income sources, but says additional funding may not be available when needed. The statements include no adjustments that might be required if the company cannot continue as a going concern. No specific financial guidance is provided.
Key risks include continued search-revenue declines and browser changes; the early-stage, uncertain commercialization prospects of quantum technology; the need for additional financing and possible dilution; acquisition integration and milestone execution; and geopolitical and military conditions in Israel. Management says customers are mainly in the U.S. and Europe and that Israeli security conditions have not directly affected operations, but the duration and economic impact remain uncertain. The company reports that Gix Media was in compliance with its bank financial covenant at September 30. It reports no material pending litigation and states that disclosure controls were effective; it expects to implement internal controls for Quantum Israel’s financial reporting.
Important facts for investors to verify
- Resolve the conflicting $9 versus $3,840 deconsolidation-loss disclosures and confirm the correct period and accounting treatment.
- Assess cash needs and financing availability against the going-concern warning and continuing operating cash outflows.
- Track search-platform revenue trends, especially the declining direct model and the durability of indirect and partner revenue.
- Review potential dilution from outstanding warrants, acquisition consideration and up to 12,702,847 additional Quantum Israel earn-out securities.
- Evaluate Quantum Israel’s milestones, commercialization timeline, operating costs and any changes to provisional acquisition valuations.
- Confirm post-quarter share issuance, warrant exercises and the status of required registration filings for resale securities.